Drug Shortage Report for MAGNESIUM SULFATE INJECTION, USP
| Report ID | 127839 |
| Drug Identification Number | 02139499 |
| Brand name | MAGNESIUM SULFATE INJECTION |
| Common or Proper name | Magnesium Sulfate Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MAGNESIUM SULFATE |
| Strength(s) | 500MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 500 mg/mL, SD Vial, 50 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-11-04 |
| Estimated end date | Unknown |
| Actual end date | 2020-12-22 |
| Shortage status | Resolved |
| Updated date | 2021-01-26 |
| Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to increased demand and production delays, we will be placing this product on 50% allocation effective today, Wednesday, November 4, 2020. AND C96410P to cover 50 % of the 50 mL demand on a 5:1 ratio) UPDATE Fresenius Kabi Canada Ltd. is pleased to advise that we will be increasing the allocation placed on our Magnesium Sulfate Injection 500 mg/mL SD Vial 50 mL to 100% effective December 22, 2020. Please note that Magnesium Sulfate Injection 500 mg/mL SD Vial 10 mL remains on 100% allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-01-26 | French | Compare |
| v3 | 2021-01-26 | English | Compare |
| v2 | 2020-11-05 | French | Compare |
| v1 | 2020-11-05 | English | Compare |
Showing 1 to 4 of 4